Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The latest update of “Global Adalimumab Biosimilar Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Adalimumab Biosimilar Market.
Overview of the Adalimumab Biosimilar Market:
The global Adalimumab Biosimilar Market report provides an encompassing study of the said market, which covers geographical regions and sub-regions in the world and provides a comprehensive outlook on market size, global sales, growth opportunities, and cost in the respective regions. The report discusses different features of the Adalimumab Biosimilar Market and offers a comprehensive analysis of historical data regarding the development of the market. It provides a detailed study on emerging trends and what strategic decisions business owners are required to take, in order to gain adequate profit during the forecast period. The report also provides the COVID-19 analysis and how the pandemic has affected the market growth and provided novel opportunities in the market.
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Adalimumab Biosimilar Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Adalimumab Biosimilar Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Momenta Pharmaceuticals
- Oncobiologics
- Coherus Biosciences
- Pfizer
- Boehringer Ingelheim
- Fujifilm Kyowa Kirin Biologics
- LG Life Sciences/Mochida Pharmaceutical
- Zydus Cadila
- Sandoz
- Samsung Bioepsis
- AET BioTech
- Amgen
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Adalimumab Biosimilar Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Exemptia
- Adalirel
- Cipleumab
- Others
By Applications, the market is segmented into:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adalimumab Biosimilar Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Adalimumab Biosimilar Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Adalimumab Biosimilar Market
1.6.1 How the Covid-19 is Affecting the Adalimumab Biosimilar Market
1.6.1.1 Adalimumab Biosimilar Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Adalimumab Biosimilar Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Adalimumab Biosimilar Market Perspective (2015-2028)
2.2 Adalimumab Biosimilar Market Growth Trends by Regions
2.2.1 Adalimumab Biosimilar Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Adalimumab Biosimilar Market Historic Market Share by Regions (2015-2021)
2.2.3 Adalimumab Biosimilar Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Adalimumab Biosimilar Market Growth Strategy
2.3.6 Primary Interviews with Key Adalimumab Biosimilar Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Adalimumab Biosimilar Market Players by Market Size
3.1.1 Global Top Adalimumab Biosimilar Market Players by Revenue (2015-2021)
3.1.2 Global Adalimumab Biosimilar Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Adalimumab Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adalimumab Biosimilar Market Concentration Ratio
3.2.1 Global Adalimumab Biosimilar Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Adalimumab Biosimilar Market Revenue in 2019
3.3 Adalimumab Biosimilar Market Key Players Head office and Area Served
3.4 Key Players Adalimumab Biosimilar Market Product Solution and Service
3.5 Date of entering into Adalimumab Biosimilar Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Adalimumab Biosimilar Market Historic Market Size by Type (2015-2021)
4.2 Global Adalimumab Biosimilar Market Forecasted Market Size by Type (2021-2028)
5 Adalimumab Biosimilar Market Breakdown Data by Application (2015-2028)
5.1 Global Adalimumab Biosimilar Market Size by Application (2015-2021)
5.2 Global Adalimumab Biosimilar Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Adalimumab Biosimilar Market Size (2015-2021)
6.2 Adalimumab Biosimilar Market Key Players in North America (2019-2021)
6.3 North America Adalimumab Biosimilar Market Size by Type (2015-2021)
6.4 North America Adalimumab Biosimilar Market Size by Application (2015-2021)
7 Europe
7.1 Europe Adalimumab Biosimilar Market Size (2015-2021)
7.2 Adalimumab Biosimilar Market Key Players in Europe (2019-2021)
7.3 Europe Adalimumab Biosimilar Market Size by Type (2015-2021)
7.4 Europe Adalimumab Biosimilar Market Size by Application (2015-2021)
8 China
8.1 China Adalimumab Biosimilar Market Size (2015-2021)
8.2 Adalimumab Biosimilar Market Key Players in China (2019-2021)
8.3 China Adalimumab Biosimilar Market Size by Type (2015-2021)
8.4 China Adalimumab Biosimilar Market Size by Application (2015-2021)
9 Japan
9.1 Japan Adalimumab Biosimilar Market Size (2015-2021)
9.2 Adalimumab Biosimilar Market Key Players in Japan (2019-2021)
9.3 Japan Adalimumab Biosimilar Market Size by Type (2015-2021)
9.4 Japan Adalimumab Biosimilar Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Adalimumab Biosimilar Market Size (2015-2021)
10.2 Adalimumab Biosimilar Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Adalimumab Biosimilar Market Size by Type (2015-2021)
10.4 Southeast Asia Adalimumab Biosimilar Market Size by Application (2015-2021)
11 India
11.1 India Adalimumab Biosimilar Market Size (2015-2021)
11.2 Adalimumab Biosimilar Market Key Players in India (2019-2021)
11.3 India Adalimumab Biosimilar Market Size by Type (2015-2021)
11.4 India Adalimumab Biosimilar Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Adalimumab Biosimilar Market Size (2015-2021)
12.2 Adalimumab Biosimilar Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Adalimumab Biosimilar Market Size by Type (2015-2021)
12.4 Central & South America Adalimumab Biosimilar Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Adalimumab Biosimilar Market Introduction
13.4 Adalimumab Biosimilar Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Adalimumab Biosimilar Market Key Market Segments
Table 2. Key Players Covered: Ranking by Adalimumab Biosimilar Market Revenue
Table 3. Ranking of Global Top Adalimumab Biosimilar Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Adalimumab Biosimilar Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Adalimumab Biosimilar Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Adalimumab Biosimilar Market Players to Combat Covid-19 Impact
Table 10. Global Adalimumab Biosimilar Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Adalimumab Biosimilar Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Adalimumab Biosimilar Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Adalimumab Biosimilar Market Share by Regions (2015-2021)
Table 14. Global Adalimumab Biosimilar Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Adalimumab Biosimilar Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Adalimumab Biosimilar Market Growth Strategy
Table 20. Main Points Interviewed from Key Adalimumab Biosimilar Market Players
Table 21. Global Adalimumab Biosimilar Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Adalimumab Biosimilar Market Share by Players (2015-2021)
Table 23. Global Top Adalimumab Biosimilar Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adalimumab Biosimilar Market as of 2019)
Table 24. Global Adalimumab Biosimilar Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Adalimumab Biosimilar Market Product Solution and Service
Table 27. Date of entering into Adalimumab Biosimilar Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Adalimumab Biosimilar Market Size by Type (2015-2021) (Million US$)
Table 30. Global Adalimumab Biosimilar Market Size Share by Type (2015-2021)
Table 31. Global Adalimumab Biosimilar Market Revenue Market Share by Type (2021-2028)
Table 31. Global Adalimumab Biosimilar Market Size Share by Application (2015-2021)
Table 33. Global Adalimumab Biosimilar Market Size by Application (2015-2021) (Million US$)
Table 34. Global Adalimumab Biosimilar Market Size Share by Application (2021-2028)
Table 35. North America Key Players Adalimumab Biosimilar Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Adalimumab Biosimilar Market Share (2019-2021)
Table 37. North America Adalimumab Biosimilar Market Size by Type (2015-2021) (Million US$)
Table 38. North America Adalimumab Biosimilar Market Share by Type (2015-2021)
Table 39. North America Adalimumab Biosimilar Market Size by Application (2015-2021) (Million US$)
Table 40. North America Adalimumab Biosimilar Market Share by Application (2015-2021)
Table 41. Europe Key Players Adalimumab Biosimilar Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Adalimumab Biosimilar Market Share (2019-2021)
Table 43. Europe Adalimumab Biosimilar Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Adalimumab Biosimilar Market Share by Type (2015-2021)
Table 45. Europe Adalimumab Biosimilar Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Adalimumab Biosimilar Market Share by Application (2015-2021)
Table 47. China Key Players Adalimumab Biosimilar Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Adalimumab Biosimilar Market Share (2019-2021)
Table 49. China Adalimumab Biosimilar Market Size by Type (2015-2021) (Million US$)
Table 50. China Adalimumab Biosimilar Market Share by Type (2015-2021)
Table 51. China Adalimumab Biosimilar Market Size by Application (2015-2021) (Million US$)
Table 52. China Adalimumab Biosimilar Market Share by Application (2015-2021)
Table 53. Japan Key Players Adalimumab Biosimilar Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Adalimumab Biosimilar Market Share (2019-2021)
Table 55. Japan Adalimumab Biosimilar Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Adalimumab Biosimilar Market Share by Type (2015-2021)
Table 57. Japan Adalimumab Biosimilar Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Adalimumab Biosimilar Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Adalimumab Biosimilar Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Adalimumab Biosimilar Market Share (2019-2021)
Table 61. Southeast Asia Adalimumab Biosimilar Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Adalimumab Biosimilar Market Share by Type (2015-2021)
Table 63. Southeast Asia Adalimumab Biosimilar Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Adalimumab Biosimilar Market Share by Application (2015-2021)
Table 65. India Key Players Adalimumab Biosimilar Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Adalimumab Biosimilar Market Share (2019-2021)
Table 67. India Adalimumab Biosimilar Market Size by Type (2015-2021) (Million US$)
Table 68. India Adalimumab Biosimilar Market Share by Type (2015-2021)
Table 69. India Adalimumab Biosimilar Market Size by Application (2015-2021) (Million US$)
Table 70. India Adalimumab Biosimilar Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Adalimumab Biosimilar Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Adalimumab Biosimilar Market Share (2019-2021)
Table 73. Central & South America Adalimumab Biosimilar Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Adalimumab Biosimilar Market Share by Type (2015-2021)
Table 75. Central & South America Adalimumab Biosimilar Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Adalimumab Biosimilar Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Adalimumab Biosimilar Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Adalimumab Biosimilar Market Share by Type: 2021 VS 2028
Figure 2. Global Adalimumab Biosimilar Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Adalimumab Biosimilar Market Report Years Considered
Figure 8. Global Adalimumab Biosimilar Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Adalimumab Biosimilar Market Share by Regions: 2021 VS 2028
Figure 10. Global Adalimumab Biosimilar Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Adalimumab Biosimilar Market Share by Players in 2019
Figure 13. Global Top Adalimumab Biosimilar Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Adalimumab Biosimilar Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Adalimumab Biosimilar Market Revenue in 2019
Figure 15. North America Adalimumab Biosimilar Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Adalimumab Biosimilar Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Adalimumab Biosimilar Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Adalimumab Biosimilar Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Adalimumab Biosimilar Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Adalimumab Biosimilar Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Adalimumab Biosimilar Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
